Category: Medmonitor

February 21, 2024
FDA Evaluates Report of Suicidal Thoughts with GLP-1 Inhibitors

While no clear link is established to these obesity and diabetes drugs, the FDA will continue to monitor data.

READ MORE
January 17, 2024
FDA Issues Respective Warnings for Compounded and Counterfeit Semaglutide

The growing demand for this drug has led individuals to search for semaglutide from alternative sources.

READ MORE
December 14, 2023
FDA Warns of Rare Drug Interactions with Antiseizure Drugs

Hypersensitivity reactions may start as a rash but can quickly result in injury to internal organs.

READ MORE
November 16, 2023
FDA Approves New Formulation of Combogesic

The acetaminophen and ibuprofen combination was approved for IV use, and as an adjunct to opioid therapy for the treatment of pain.

READ MORE
October 19, 2023
New Depression Product and Diabetes Generic Approvals

Exuua was approved for major depressive disorder, while two diabetes medications receive generic approvals.

READ MORE
August 24, 2023
Tornado Damages Pfizer Pharmaceutical Plant, Drug Shortages May Follow

As other Pfizer plants shift gears to make up for this damage, overall drug manufacturing may slow in some areas.

READ MORE
July 25, 2023
FDA Publishes Guidance on Clinical Trials for Psychedelic Drugs

These guidelines advise researchers on study design and other considerations as they develop medications that contain psychedelics.

READ MORE
June 21, 2023
Brixadi Approved for Opioid Use Disorder

A new buprenorphine injection will be available for weekly or monthly dosages, administered by providers.

READ MORE
May 22, 2023
Drug Recalls for Pain Medications

Teva is recalling certain lots of fentanyl buccal tablets, while Family Dollar is recalling Advil that was not kept at proper temperature.

READ MORE
April 18, 2023
FDA Approves First Over-the-Counter Naloxone Nasal Spray

Patients will no longer need a prescription for this opioid overdose antidote.

READ MORE
1 2 3 8
lockenvelopephone-handsetmagnifiermenucross-circle